Persistent Challenges in Pediatric Pulmonary Hypertension.
暂无分享,去创建一个
[1] W. Chung,et al. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society , 2015, Circulation.
[2] L. Lusk,et al. Short-Term Treprostinil Use in Infants with Congenital Diaphragmatic Hernia following Repair. , 2015, The Journal of pediatrics.
[3] P. McNamara,et al. Persistent pulmonary hypertension of the newborn: Advances in diagnosis and treatment. , 2015, Seminars in fetal & neonatal medicine.
[4] L. Romer,et al. Trends in Hospitalization for Pediatric Pulmonary Hypertension , 2015, Pediatrics.
[5] D. Morales,et al. Trends in Pediatric Pulmonary Hypertension–Related Hospitalizations in the United States from 2000–2009 , 2015, Pulmonary circulation.
[6] B. Thébaud,et al. Stem Cells for the Prevention of Neonatal Lung Disease , 2015, Neonatology.
[7] R. Sachdeva,et al. Tricuspid Annular Plane Systolic Excursion Is Reduced in Infants with Pulmonary Hypertension , 2015, Echocardiography.
[8] A. Lapointe,et al. Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Infants with Bronchopulmonary Dysplasia , 2015, Pediatric Cardiology.
[9] J. Feinstein,et al. Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients , 2015, Front. Pediatr..
[10] M. Humbert,et al. Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[11] I. Adatia,et al. Cardiac Catheterization in Children with Pulmonary Hypertensive Vascular Disease , 2015, Pediatric Cardiology.
[12] N. Gotteiner,et al. Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension. , 2014, Placenta.
[13] H. Hillege,et al. Identification of treatment goals in paediatric pulmonary arterial hypertension , 2014, European Respiratory Journal.
[14] L. Lusk,et al. B-type natriuretic peptide: a prognostic marker in congenital diaphragmatic hernia , 2014, Pediatric Research.
[15] U. Krishnan,et al. Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy , 2014, Pediatrics.
[16] M. Quail,et al. Real-Time Magnetic Resonance Assessment of Septal Curvature Accurately Tracks Acute Hemodynamic Changes in Pediatric Pulmonary Hypertension , 2014, Circulation. Cardiovascular imaging.
[17] Han-Suk Kim,et al. Serial Changes of Serum Endostatin and Angiopoietin-1 Levels in Preterm Infants with Severe Bronchopulmonary Dysplasia and Subsequent Pulmonary Artery Hypertension , 2014, Neonatology.
[18] D. Ivy,et al. STARTS-2: Long-Term Survival With Oral Sildenafil Monotherapy in Treatment-Naive Pediatric Pulmonary Arterial Hypertension , 2014, Circulation.
[19] Jegen Kandasamy,et al. B-type natriuretic peptide and mortality in extremely low birth weight infants with pulmonary hypertension: a retrospective cohort analysis , 2014, BMC Pediatrics.
[20] F. Friedmacher,et al. Decreased apelin and apelin-receptor expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia , 2014, Pediatric Surgery International.
[21] C. Thomson,et al. Pediatric pulmonary hypertension. , 2013, Journal of the American College of Cardiology.
[22] E. Nozik-Grayck,et al. Pulmonary artery endothelial cell dysfunction and decreased populations of highly proliferative endothelial cells in experimental congenital diaphragmatic hernia. , 2013, American journal of physiology. Lung cellular and molecular physiology.
[23] Robin Shandas,et al. Wall shear stress measured by phase contrast cardiovascular magnetic resonance in children and adolescents with pulmonary arterial hypertension , 2013, Journal of Cardiovascular Magnetic Resonance.
[24] R. Naeije,et al. Downregulated bone morphogenetic protein signaling in nitrofen-induced congenital diaphragmatic hernia , 2013, Pediatric Surgery International.
[25] W. Chung,et al. Outcomes of congenital diaphragmatic hernia in the modern era of management. , 2013, The Journal of pediatrics.
[26] R. Romero,et al. Fetal production of growth factors and inflammatory mediators predicts pulmonary hypertension in congenital diaphragmatic hernia , 2013, Pediatric Research.
[27] M. Friedberg,et al. Prognostic significance of 2-dimensional, M-mode, and Doppler echo indices of right ventricular function in children with pulmonary arterial hypertension. , 2013, American heart journal.
[28] J. Feinstein,et al. Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[29] Jeffrey Feinstein,et al. Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension , 2013, Pulmonary circulation.
[30] Mark J Schuuring,et al. Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease. , 2013, International journal of cardiology.
[31] D. Ivy,et al. Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension , 2013, Pediatric pulmonology.
[32] N. Gotteiner,et al. Fetal Growth Restriction and Pulmonary Hypertension in Premature Infants with Bronchopulmonary Dysplasia , 2012, Journal of Perinatology.
[33] W. Carlo,et al. Prospective Analysis of Pulmonary Hypertension in Extremely Low Birth Weight Infants , 2012, Pediatrics.
[34] G. Raskob,et al. Clinical features of paediatric pulmonary hypertension: a registry study , 2012, The Lancet.
[35] H. Hillege,et al. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. , 2011, European heart journal.
[36] L. Gortner,et al. Serum Cytokine Levels in Neonates with Congenital Diaphragmatic Hernia , 2011, Klinische Pädiatrie.
[37] R. Barst,et al. Survival in Childhood Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management , 2011, Circulation.
[38] T. Delhaas,et al. Pediatric Pulmonary Hypertension in the Netherlands: Epidemiology and Characterization During the Period 1991 to 2005 , 2011, Circulation.
[39] P. Rozance,et al. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[40] Chang Won Choi,et al. Risk Factors for Pulmonary Artery Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia , 2011, Neonatology.
[41] S. Harikrishnan,et al. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011 , 2011, Pulmonary circulation.
[42] S. Harikrishnan,et al. Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011 , 2011, Pulmonary circulation.
[43] R. Barst,et al. Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings. , 2010, The American journal of cardiology.
[44] B. Poindexter,et al. Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.
[45] J. Neuhaus,et al. Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. , 2010, American journal of respiratory and critical care medicine.
[46] C. Sartori,et al. Pulmonary and Systemic Vascular Dysfunction in Young Offspring of Mothers With Preeclampsia , 2010, Circulation.
[47] E. Bae,et al. Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia , 2010, Korean circulation journal.
[48] S. Bratton,et al. Perioperative complications in children with pulmonary hypertension undergoing general anesthesia with ketamine , 2010, Paediatric anaesthesia.
[49] S. Abman,et al. Towards improving the care of children with pulmonary hypertension: The rationale for developing a Pediatric Pulmonary Hypertension Network. , 2009, Progress in pediatric cardiology.
[50] Horst Olschewski,et al. Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[51] W. Ravekes,et al. Right ventricular function in infants, children and adolescents: reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[52] D. Ivy,et al. Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension. , 2009, Chest.
[53] A. Hislop,et al. Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001–2006 , 2008, Heart.
[54] K. Maher,et al. Pulmonary Vein Stenosis: Prematurity and Associated Conditions , 2008, Pediatrics.
[55] P. Mourani,et al. Clinical Utility of Echocardiography for the Diagnosis and Management of Pulmonary Vascular Disease in Young Children With Chronic Lung Disease , 2008, Pediatrics.
[56] D. McElhinney,et al. Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era , 2007, Pediatrics.
[57] A. McEwan,et al. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. , 2007, British journal of anaesthesia.
[58] R. Friesen,et al. Perioperative Complications in Children with Pulmonary Hypertension Undergoing Noncardiac Surgery or Cardiac Catheterization , 2007, Anesthesia and analgesia.
[59] C. Bower,et al. Outcomes of Congenital Diaphragmatic Hernia: A Population-Based Study in Western Australia , 2005, Pediatrics.
[60] M. Humbert,et al. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.
[61] R. Speich,et al. Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[62] P. Dillon,et al. The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia. , 2004, Journal of pediatric surgery.
[63] A. Fenton,et al. Nihilism in the 1990s: the true mortality of congenital diaphragmatic hernia. , 2003, Pediatrics.
[64] B. Yoder,et al. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[65] R. Barst,et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension , 2003, Clinical pharmacology and therapeutics.
[66] D. Carlton,et al. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[67] G. Maislin,et al. Vasodilator therapy for primary pulmonary hypertension in children. , 1999, Circulation.
[68] J. Vacanti,et al. Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. , 1985, The Journal of pediatrics.
[69] A. Weyman,et al. Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study. , 1982, Circulation.
[70] B. Poindexter,et al. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. , 2015, American journal of respiratory and critical care medicine.
[71] S. Karumanchi,et al. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. , 2012, American journal of physiology. Lung cellular and molecular physiology.